Investors to Interact with Corporate Executives from Cardinal Health, Inc. and Other Companies at Biotech/Healthcare Stocks Forum in New York


RICHMOND, Va., March 11, 2002 (PRIMEZONE) --



 The Forum, to be held March 23 at E*TRADE Financial New York Center,
    will provide investors the opportunity to hear analyst-style 
       presentations and question company executives directly
                   by attending onsite or online

Healthcare and Biotech sector companies including Cardinal Health, Inc. (NYSE:CAH), Gene Logic, Inc. (Nasdaq:GLGC), OraPharma, Inc. (Nasdaq:OPHM) and VaxGen (Nasdaq:VXGN) will be speaking directly to investors at a Forum to be held in New York on March 23. A total of six companies and two industry experts will be presenting at the event, which is open to the public and will take place at the E*TRADE Financial New York Center. By attending this Forum, onsite or online at www.informedinvestors.com, investors can hear directly from company executives and get their investment information straight from the source.

Executives from each company will give 20 minute analyst-style presentations, and a 5-10 minute question and answer session with the investor audience follows each presentation. The event, produced by Informed Investors, will take place from 10 a.m. to 3 p.m. Kate Bohner, noted financial writer and CNBC Business News reporter, will serve as master of ceremonies. All presentations will be archived on the Internet at www.informedinvestors.com, www.vcall.com and www.investorconference.com. Information and registration are available at www.informedinvestors.com or by calling 888-301-6618.

One of two keynote addresses will be delivered by Robert S. Kass, Ph.D., Chairman of Pharmacology Department at Columbia University. Dr. Kass's works have been published in Science Magazine and The Journal of Biological Chemistry. His Department's interests currently include such diverse problems as the identification of molecular signals that determine whether a cell lives or dies to the discovery of new drugs that control cardiac rhythm in inherited and non-inherited heart disease. Dr. Kass's extensive biomedical research and his insight regarding the development of drugs will give investors a unique perspective on Biotech and Healthcare investing.

Cardinal Health, Inc. is a provider of products and services to healthcare providers and manufacturers, helping them improve the efficiency and quality of their healthcare services and products. Cardinal Health has four reporting segments: Pharmaceutical Distribution and Provider Services, Medical-Surgical Products and Services, Pharmaceutical Technologies and Services, and Automation and Information Services. Steve Fischbach, VP Investor Relations will be presenting at the Forum at 11:45.

Robert G. Burrows, Director, Corporate Communications for Gene Logic will be presenting at 10:45 a.m. EST. Gene Logic Inc. is a leading provider of genomic information and bioinformatics products related to gene activity in human disease and toxicity to reduce the time, risk and cost of global pharmaceutical, biotechnology and life science drug discovery and development.

VaxGen is the leading developer of preventive HIV/AIDS vaccines. They will be represented by Lance Ignon, Vice President of Corporate Communications at their 1:30 presentation.

Michael Kishbauch, President and CEO of OraPharma, will talk to investors at 11:15. OraPharma, Inc. is a specialty pharmaceutical company that is engaged in discovering, developing and marketing pharmaceutical products for oral healthcare. The Company has received approval from the United States Food and Drug Administration to market Arestin, and they have been marketing that product since early 2001. OraPharma has additional products in earlier stages of development.

Informed Investors is the leading producer of online and offline industry-specific investment conferences for individual investors and a member of the World Investor Link family of companies serving self-reliant investors.

About World Investor Link: Since 1992, World Investor Link (www.worldinvestorlink.com) has opened information channels between public companies and potential investors. This year World Investor Link will make more than 5 million investor introductions to over 4,600 corporate clients through services including The Annual Reports Service, The Fund Info Service, Vcall (www.vcall.com) Investor Conference (www.investorconference.com) and Informed Investors Forums (www.informedinvestors.com). These services provide investors free access to onsite and Webcast investor events and company financial reports through World Investor Link's relationships with over 204 leading financial media channels including The Wall Street Journal, Financial Times, Barron's and Yahoo!Finance. For companies and mutual funds, these services enable compliance with regulation fair-disclosure requirements and provide visibility with investors at the precise point investors are making decisions. World Investor Link, Inc., a wholly owned subsidiary of WILink.com plc (WLK on The London Stock Exchange), began operations in Richmond, Va. in 1993.



            

Contact Data